Sangseok Lee1, Hong-Seuk Yang, Tomoki Sasakawa, Mohammed A S Khan, Ashok Khatri, Masao Kaneki, J A Jeevendra Martyn. 1. From Massachusetts General Hospital, Shriners Hospitals for Children®, Boston, Massachusetts, and Harvard Medical School, Boston, Massachusetts (S.L., H.-s.Y., T.S., M.A.S.K.); the Peptide Core Facility, Massachusetts General Hospital (A.K.); the Signal Transduction Laboratory, Massachusetts General Hospital, and Harvard Medical School (M.K.), the Clinical and Biochemical Pharmacology Laboratory, Massachusetts General Hospital, Shriners Hospitals for Children®, and Harvard Medical School (J.A.J.M.). Current positions: Sang-gye Paik Hospital, College of Medicine, In-Je University, Seoul, South Korea (S.L.), Department of Anesthesiology, Asan Medical Center, University of Ulsan, Seoul, South Korea (H.-s.Y.), Asahikawa University, Asahikawa, Japan (T.S.).
Abstract
BACKGROUND: Mature acetylcholine receptor (AChR) isoform normally mediates muscle contraction. The hypothesis that α7AChRs up-regulate during immobilization and contribute to neurotransmission was tested pharmacologically using specific blockers to mature (waglerin-1), immature (αA-OIVA), and α7AChRs (methyllycaconitine), and nonspecific muscle AChR antagonist, α-bungarotoxin. METHODS: Mice were immobilized; contralateral limbs were controls. Fourteen days later, anesthetized mice were mechanically ventilated. Nerve-stimulated tibialis muscle contractions on both sides were recorded, and blockers enumerated above sequentially administered via jugular vein. Data are mean ± standard error. RESULTS: Immobilization (N = 7) induced tibialis muscle atrophy (40.6 ± 2.8 vs. 52.1 ± 2.0 mg; P < 0.01) and decrease of twitch tension (34.8 ± 1.1 vs. 42.9 ± 1.5 g; P < 0.01). Waglerin-1 (0.3 ± 0.05 μg/g) significantly (P = 0.001; N = 9) depressed twitch tension on contralateral (≥97%) versus immobilized side (approximately 45%). Additional waglerin-1 (total dose 1.06 ± 0.12 μg/g or approximately 15.0 × ED50 in normals) could not depress twitch of 80% or greater on immobilized side. Immature AChR blocker, αA-OIVA (17.0 ± 0.25 μg/g) did not change tension bilaterally. Administration of α-bungarotoxin (N = 4) or methyllycaconitine (N = 3) caused 96% or greater suppression of the remaining twitch tension on immobilized side. Methyllycaconitine, administered first (N = 3), caused equipotent inhibition by waglerin-1 on both sides. Protein expression of α7AChRs was significantly (N = 3; P < 0.01) increased on the immobilized side. CONCLUSIONS: Ineffectiveness of waglerin-1 suggests that the twitch tension during immobilization is maintained by receptors other than mature AChRs. Because αA-OIVA caused no neuromuscular changes, it can be concluded that immature AChRs contribute minimally to neurotransmission. During immobilization approximately 20% of twitch tension is maintained by up-regulation of α-bungarotoxin- and methyllycaconitine-sensitive α7AChRs.
BACKGROUND: Mature acetylcholine receptor (AChR) isoform normally mediates muscle contraction. The hypothesis that α7AChRs up-regulate during immobilization and contribute to neurotransmission was tested pharmacologically using specific blockers to mature (waglerin-1), immature (αA-OIVA), and α7AChRs (methyllycaconitine), and nonspecific muscle AChR antagonist, α-bungarotoxin. METHODS:Mice were immobilized; contralateral limbs were controls. Fourteen days later, anesthetized mice were mechanically ventilated. Nerve-stimulated tibialis muscle contractions on both sides were recorded, and blockers enumerated above sequentially administered via jugular vein. Data are mean ± standard error. RESULTS: Immobilization (N = 7) induced tibialis muscle atrophy (40.6 ± 2.8 vs. 52.1 ± 2.0 mg; P < 0.01) and decrease of twitch tension (34.8 ± 1.1 vs. 42.9 ± 1.5 g; P < 0.01). Waglerin-1 (0.3 ± 0.05 μg/g) significantly (P = 0.001; N = 9) depressed twitch tension on contralateral (≥97%) versus immobilized side (approximately 45%). Additional waglerin-1 (total dose 1.06 ± 0.12 μg/g or approximately 15.0 × ED50 in normals) could not depress twitch of 80% or greater on immobilized side. Immature AChR blocker, αA-OIVA (17.0 ± 0.25 μg/g) did not change tension bilaterally. Administration of α-bungarotoxin (N = 4) or methyllycaconitine (N = 3) caused 96% or greater suppression of the remaining twitch tension on immobilized side. Methyllycaconitine, administered first (N = 3), caused equipotent inhibition by waglerin-1 on both sides. Protein expression of α7AChRs was significantly (N = 3; P < 0.01) increased on the immobilized side. CONCLUSIONS: Ineffectiveness of waglerin-1 suggests that the twitch tension during immobilization is maintained by receptors other than mature AChRs. Because αA-OIVA caused no neuromuscular changes, it can be concluded that immature AChRs contribute minimally to neurotransmission. During immobilization approximately 20% of twitch tension is maintained by up-regulation of α-bungarotoxin- and methyllycaconitine-sensitive α7AChRs.
Authors: Xueyong Wang; Kathrin L Engisch; Russell W Teichert; Baldomero M Olivera; Martin J Pinter; Mark M Rich Journal: J Neurosci Date: 2006-08-30 Impact factor: 6.167
Authors: N Moser; N Mechawar; I Jones; A Gochberg-Sarver; A Orr-Urtreger; M Plomann; R Salas; B Molles; L Marubio; U Roth; U Maskos; U Winzer-Serhan; J-P Bourgeois; A-M Le Sourd; M De Biasi; H Schröder; J Lindstrom; A Maelicke; J-P Changeux; A Wevers Journal: J Neurochem Date: 2007-04-10 Impact factor: 5.372
Authors: Russell W Teichert; Carmen C Garcia; Joseph G Potian; James J Schmidt; Veit Witzemann; Baldomero M Olivera; Joseph J McArdle Journal: Ann N Y Acad Sci Date: 2008 Impact factor: 5.691
Authors: Heidrun Fink; Marc Helming; Christoph Unterbuchner; Andrea Lenz; Frauke Neff; J A Jeevendra Martyn; Manfred Blobner Journal: Crit Care Med Date: 2008-03 Impact factor: 7.598
Authors: Stefan J Schaller; Michio Nagashima; Martin Schönfelder; Tomoki Sasakawa; Fabian Schulz; Mohammed A S Khan; William R Kem; Gerhard Schneider; Jürgen Schlegel; Heidrun Lewald; Manfred Blobner; J A Jeevendra Martyn Journal: Pflugers Arch Date: 2018-07-13 Impact factor: 3.657
Authors: Shailesh Agarwal; Shawn J Loder; David Cholok; John Li; Guowu Bian; Srilakshmi Yalavarthi; Shuli Li; William F Carson; Charles Hwang; Simone Marini; Chase Pagani; Nicole Edwards; Matthew J Delano; Theodore J Standiford; Jason S Knight; Steven L Kunkel; Yuji Mishina; Peter A Ward; Benjamin Levi Journal: Front Immunol Date: 2019-10-24 Impact factor: 7.561